References
- Pergolzzi RG, Kreis W, Rottach C, et al. Mutational status of codons 12 and 13 of the N- and K-ras penes in tissue and cell lines derived from primary and metastatic prostate carcinomas. Cancer Invest 1993; 11: 25–32
- Carter B, Epstein J, Isaacs W. ras gene mutations in human prostate cancer. Cancer Res 1990; 50: 6830–6832
- Gumerlock P, Poonamallee U, Meyers F, et al. Activated rus alleles in human carcinoma of the prostate are rare. Cancer Res 1991; 51: 1632–1637
- Bos JL. ras oncogenes in human cancer: A review. Cancer Res 1990; 49: 4682–3689
- Sukumur S, Armstrong B, Bruyntjes JP, et al. Frequent activation of Ki-ras oncogene at codon 12 in N-methyl-N-nitrosourea induced rat prostate carcinomas and neurogenic sarcomas. Mol Carcinogen 1991; 4: 362–368
- Voeller HJ, Wilding G, Gelman GP. v-ras H expression confers hormonc independent in vitro growth to LNCaP prostate carcinoma cells. Mol Endocrinol 1991; 5: 204–216
- Ichikawa T, Schalken Ichikdwa JA, et al. H-ras expression. genetic instability and acquisition of metastatic ability by rat prostatic carcinoma cells following v-H-ras transfection. Prostate 1991; 18: 163–172
- Merz VW, Miller GJ, Krebs T, et al. Elevated transforming growth factor-beta I and beta 3 mRNA levels are associated with ras + myc-induced carcinomas in reconstituted mouse prostate: Evidence for a paracrine role during progression. Mol Endocrinol 1991; 5: 503–513
- Atkin NB, Baker MC. Chromosome study of 5 cancers of the prostate. Hum Genet 1985; 70: 3551–364
- Brothman AR, Reehl D, Patel AM, et al. Frequency and pattern of karyotypic abnormalities in human prostate cancer. Cancer Res 1990; 50: 3745–3803
- Lee SE, Cumin SM, Paulson DF, et al. Flow cytometric determination of ploidy in prostatic adenocarcinoma: A comparison with seminal vesicle involvement and histopathologic grading as a predictor of clinical recurrence. J Urol 1988; 140: 769–774
- Ritchie AWS, Dorey F, Layfield JL, et al. Relationship of DNA content to conventional prognostic factors in clinically localized carcinoma of the prostate. Elr J Uroll 1988; 62: 254–269
- Carter B, Ewing C, Ward US, et al. Allelic loss of Ihq and 10q on human prostate cancer. Proc Natl Acad Sci USA 1990; 87: 8751–8755
- Isaacs W, Carter B, Ewing C. Wild-type p53 suppresses growth of human prostate cancer cells containing mutant p53 alleles. Cancer Res 1991; 51: 4716–4720
- Bookstein R, Rio P, Madroperla S, et al. Promoter deletion and loss of retinoblastoma gene expression in human prohtate carcinoma. Proc Natl Acad Sci USA 1990; 87: 7762–7766